Malignant struma ovarii: Recurrence and response to treatment monitored by thyroglobulin levels

Gynecologic Oncology

Volumn 70, Issue 3, 1998, Pages 425-427

  Rose, Peter G ^a   Arafah, Baha ^a   Abdul Karim, Fadi W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; TERATOMA; THYROGLOBULIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0032169022     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5056     Document Type: Article

References (14)

1. Devaney K, Snyder R, Norris H J, Tavassoli F A. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol. 12:1993;333-343.
2. Woodruff J D, Markley R L. Struma ovarii. Obstet Gynecol. 9:1957;707-719.
3. Woodruff J D, Rauh J T, Markley R L. Ovarian struma. Obstet Gynecol. 27:1966;194-201.
4. Kempers R D, Dockerty M B, Hoffman D L, Bartholomew L G. Struma ovarii-ascitic, hyperthyroid, and asymptomatic syndromes. Ann Int Med. 72:1970;883-893.
5. Hasleton P S, Kelehan P, Whittaker J S, Burslem R W, Turner L. Benign and malignant struma ovarii. Arch Pathol Lab Med. 102:1978;180-184.
6. Pardo-Mindan F J, Vazquez J J. Malignant struma ovarii: Light and electron microscopic study. Cancer. 51:1983;337-343.
7. 131. Cancer. 60:1987;178-182.
8. Rosenblum N G, LiVolsi V A, Edmonds P R, Mikuta J J. Malignant struma ovarii. Gynecol Oncol. 32:1989;224-227.
9. O'Connell M EA, Fisher C, Harmer C L. Malignant struma ovarii: presentation and management. Br J Radiol. 63:1990;360-363.
10. Zakhem A, Aftimos G, Kreidy R, Salem P. Malignant struuma ovarii: report of two cases and selected review of the literature. J Surg Oncol. 43:1990;61-65.
11. Thomas R D, Batty V B. Metastatic malignant struma ovarii: two case reports. Clin Nuclear Med. 17:1992;577-578.
12. Vadmal M S, Smilari T F, Lovecchio J L, Klein I L, Hajdu S I. Diagnosis and treatment of disseminated struma ovarii with malignant transformation. Gynecol Oncol. 64:1997;541-546.
13. Ronga G, Fiorentino A, Paserie E. Can iodine 131 whole body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma. J Nuclear Med. 31:1990;1766-1771.
14. Lubin E, Mechlis-Frish, Zata S. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nuclear Med. 35:1994;257-262.